Application

15821530 · PSMA Targeting Trispecific Proteins and Methods of Use

Filed 2017-11-22 · Granted · Patent 10844134 (2020-11-24) The official file ↗The patent and its PDF ↗ · Art unit 1643 · Examiner Stephen L Rawlings Typical · CPC C07K 16/3069 · Harpoon Therapeutics, Inc. · MERCK

Office actions

first was Restriction requirement

RCEs

no appeal

To first action

3.9 mo

to disposition 36.1 mo

Statutes raised

103 112 DP

3 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.